Medical University of Warsaw clinical trial pipeline

3 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 1 with a minor change only.

1. Notable

   Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP…Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression

   Primary completion pushed from Sep 2026 to Sep 2027

   Also in this update: Study completion pushed from Sep 2027 to Sep 2028

   Medical University of Warsaw·Not applicable· NCT06975332· Registry history of NCT06975332 on ClinicalTrials.gov (opens the registry)

   Oct 13, 2026

2. Notable

   EPA-DBS · Physical Activity on the Course of Parkinson's Disease…EPA-DBS · Physical Activity on the Course of Parkinson's Disease · Bilateral DBS-STN Stimulation

   Primary endpoint(s) modified

   Medical University of Warsaw·Not applicable· NCT07838636· Registry history of NCT07838636 on ClinicalTrials.gov (opens the registry)

   Oct 6, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.